Author:
Roksnoer Lodi C.W.,van Veghel Richard,de Vries René,Garrelds Ingrid M.,Bhaggoe Usha M.,Friesema Edith C.H.,Leijten Frank P.J.,Poglitsch Marko,Domenig Oliver,Clahsen-van Groningen Marian C.,Hoorn Ewout J.,Jan Danser A.H.,Batenburg Wendy W.
Reference52 articles.
1. Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study;de Boer;J Renin Angiotensin Aldosterone Syst,2012
2. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase;Seymour;J Cardiovasc Pharmacol,1991
3. Renin–angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure;von Lueder;Circ Heart Fail,2013
4. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo;Ferro;Circulation,1998
5. Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin;Ando;Hypertension,1995
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献